Edoxaban DU - 176b CAS 480449 70 5 GMP DMF C24H30ClN7O4S

Edoxaban DU - 176b CAS : 480449-70-5 GMP DMF

Name : Edoxaban

CAS No . : 480449-70-5

Synonym : DU - 176b

Chemical Name : N' - ( 5 - chloropyridin - 2 - yl ) - N - [ ( 1S , 2R , 4S ) - 4 - ( dimethylcarbamoyl ) - 2 - [ ( 5 - methyl - 6 , 7 - dihydro - 4H - [ 1 , 3 ] thiazolo [ 5 , 4-c ] pyridine - 2 - carbonyl ) amino ] cyclohexyl ] oxamide

Molecular Formula : C24H30ClN7O4S

Molecular Weight : 548.06

Description: Edoxaban is the active pharmaceutical ingredient (API) of branded drug Savaysa or Lixiana. The innovator of Edoxaban is a Japanese company called Daiichi Sankyo. Edeoxaban was approved in 2011 in Japan and by FDA in USA in 2015. Edoxaban is an anticoagulant drug for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). The patients with nonvalvular atrial fibrillation (NVAF) use it to reduce the risk of systemic embolism (SE) and stroke.

The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.